Literature DB >> 8783325

A case of uncommon withdrawal symptoms after a short period of spinal morphine administration.

Jacques Devulder1, Peter Bohyn, Frédéric Castille, Martine De Laat, Georges Rolly.   

Abstract

A 54-year-old female with chronic failed back surgery syndrome and pain in the back and the right leg was treated by chronic spinal morphine administration by an external pump. After a positive test instillation over a 3-week period the spinal catheter was removed. Within 24 h the patient developed fever, leucocytosis, impaired sense of smell and allodynia and hyperpathia in all 4 limbs. Infection was excluded as a possible cause and a withdrawal after a second test period some weeks later reinitiated the symptoms. The symptoms vanished after restarting the morphine administration. Finally, an internal Medtronic pump was implanted because the patient obtained good pain relief with the test instillation. Good pain relief could be obtained with the daily instillation of 5 mg morphine intrathecally. Fever, leucocytosis, impaired sense of smell, allodynia and hyperpathia in the limbs reappeared a few weeks later. Evaluation showed catheter migration out of the spinal canal.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8783325     DOI: 10.1016/0304-3959(95)00187-5

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  3 in total

Review 1.  Acute pain management for patients receiving maintenance methadone or buprenorphine therapy.

Authors:  Daniel P Alford; Peggy Compton; Jeffrey H Samet
Journal:  Ann Intern Med       Date:  2006-01-17       Impact factor: 25.391

2.  Thermal sensitivity as a measure of spontaneous morphine withdrawal in mice.

Authors:  Rebecca E Balter; Linda A Dykstra
Journal:  J Pharmacol Toxicol Methods       Date:  2013-02-14       Impact factor: 1.950

3.  Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal.

Authors:  Lisa L Wilson; Soumen Chakraborty; Shainnel O Eans; Thomas J Cirino; Heather M Stacy; Chloe A Simons; Rajendra Uprety; Susruta Majumdar; Jay P McLaughlin
Journal:  Cell Mol Neurobiol       Date:  2021-01-12       Impact factor: 4.231

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.